The Emerging Role of HDL Cholesterol: Is it Time to Focus More Energy on Raising High-Density Lipoprotein Levels?

References

• Levini GN, Keaney JF Jr, Vita JA. Cholesterol reduction in cardiovascular disease: clinical benefits and possible mechanisms. N Engl J Med 1995; 332(8): 512-21
   PubMed Web of Science ®Google Scholar
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344(8934): 1383-9
   PubMed Web of Science ®Google Scholar
• Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med 1998: 339(19): 1349-57
   PubMedGoogle Scholar
• Castelli WP, Garrison RJ, Wilson PW, et al. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. JAMA 1986; 256(20): 2835-8
   Google Scholar
• Shah PK, Amin J. Low high density lipoprotein level is associated with increased restenosis rate after coronary angioplasty. Circulation 1992; 85(4): 1279-85
   PubMed Web of Science ®Google Scholar
• Rubins HB, Robins SJ, Collins D, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 1999; 341(6): 410-8
   PubMed Web of Science ®Google Scholar
• Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998; 279(20): 1615-22
   Google Scholar
• Kwiterovich PO Jr. The antiatherogenic role of high-density lipoprotein cholesterol. Am J Cardiol 1998; 82(9A): 13Q-21Q
   PubMed Web of Science ®Google Scholar
• Tall AR. An overview of reverse cholesterol transport. Eur Heart J 1998; 19 Suppl A: A31-5
   PubMedGoogle Scholar
• Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA 1993; 269(23): 3015-23
   Google Scholar
• Garrison RJ, Kannel WB, Feinleib M, et al. Cigarette smoking and HDL cholesterol: the Framingham Offspring Study. Atherosclerosis 1978; 30(1): 17-25
   PubMed Web of Science ®Google Scholar
• Moskowitz WB, Mosteller M, Schieken RM, et al. Lipoprotein and oxygen transport alterations in passive smoking preadolescent children: the MCV Twin Study. Circulation 1990; 81 (2): 586-92
   PubMed Web of Science ®Google Scholar
• Ludviksdottir D, Blondal T, Franzon M, et al. Effects of nicotine nasal spray on atherogenic and thrombogenic factors during smoking cessation. J Intern Med 1999; 246(1): 61-6
   PubMed Web of Science ®Google Scholar
• Gibbons LW, Blair SN, Cooper KH, et al. Association between coronary heart disease risk factors and physical fitness in healthy adult women. Circulation 1983; 67(5): 977-83
   PubMed Web of Science ®Google Scholar
• Cauley JA, Kriska AM, LaPorte RE, et al. A two year randomized exercise trial in older women: effects on HDL cholesterol. Atherosclerosis 1987; 66(3): 247-58
   PubMed Web of Science ®Google Scholar
• Kokkinos PF, Holland JC, Narayan P, et al. Miles run per week and high-density lipoprotein cholesterol levels in healthy, middle-aged men: a dose-response relationship. Arch Intern Med 1995; 155(4): 415-20
   PubMedGoogle Scholar
• Suh I, Shaten BJ, Cutler JA, et al. Alcohol use and mortality from coronary heart disease: the role of high-density lipoprotein cholesterol. The Multiple Risk Factor Intervention Trial Research Group. Ann Intern Med 1992; 116(11): 881-7
   PubMed Web of Science ®Google Scholar
• Langer RD, Criqui MH, Reed DM. Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease. Circulation 1992; 85(3): 910-5
   PubMed Web of Science ®Google Scholar
• Denke MA, Sempos CT, Grundy SM. Excess body weight: an underrecognized contributor to high blood cholesterol levels in white American men. Arch Intern Med 1993; 153(9): 1093-103
   PubMedGoogle Scholar
• Hubert HB, Feinleib M, McNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67(5): 968-77
   PubMed Web of Science ®Google Scholar
• Lamon-Fava S, Wilson PW, Schaefer EJ. Impact of body mass index on coronary heart disease risk factors in men and women: the Framingham Offspring Study. Arterioscler Thromb Vase Biol 1996; 16(12): 1509-15
   PubMed Web of Science ®Google Scholar
• Denke MA, Sempos CT, Grundy SM. Excess body weight: an under-recognized contributor to dyslipidemia in white American women. Arch Intern Med 1994; 154(4): 401-10
   PubMedGoogle Scholar
• Wood PD, Stefanick ML, Dreon DM, et al. Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. N Engl J Med 1988; 319(18): 1173-9
   PubMed Web of Science ®Google Scholar
• Wood PD, Stefanick ML, Williams PT, et al. The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women. N Engl J Med 1991; 325(7): 461-6
   PubMed Web of Science ®Google Scholar
• Mensink RP, Katan MB. Effect of monounsaturated fatty acids versus complex carbohydrates on high-density lipoproteins in healthy men and women. Lancet 1987; 1(8525): 122-5
   PubMed Web of Science ®Google Scholar
• de Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean al-pha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994; 343(8911): 1454-9
   PubMed Web of Science ®Google Scholar
• Hu FB, Stampfer MJ, Manson JE, et al. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 1997; 337(21): 1491-9
   PubMed Web of Science ®Google Scholar
• Miettinen TA, Puska P, Gylling H, et al. Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N Engl J Med 1995; 333(20): 1308-12
   PubMed Web of Science ®Google Scholar
• Bush TL, Barrett-Connor E, Cowan LD, et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987; 75(6): 1102-9
   PubMed Web of Science ®Google Scholar
• Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses’ Health Study. N Engl J Med 1991; 325(11): 756-62
   PubMed Web of Science ®Google Scholar
• Connelly PW, Stachenko S, MacLean DR, et al. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group. Can J Cardiol 1999; 15(4): 419-27
   Google Scholar
• Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA 1995; 273(3): 199-208
   Google Scholar
• Walsh BW, Schiff I, Rosner B, et al. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991; 325(17): 1196-204
   PubMed Web of Science ®Google Scholar
• Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998; 280(7): 605-13
   Google Scholar
• Canner PL, Berge KG, Wenger NK, et al. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol 1986; 8(6): 1245-55
   PubMed Web of Science ®Google Scholar
• Choice of lipid-lowering drugs. Med Lett Drugs Ther 1998: 40(1042): 117-9
   PubMed Web of Science ®Google Scholar